Literature DB >> 9369250

Heritability of left ventricular mass: the Framingham Heart Study.

W S Post1, M G Larson, R H Myers, M Galderisi, D Levy.   

Abstract

Left ventricular hypertrophy is associated with an increased risk for cardiovascular disease. The known determinants of left ventricular hypertrophy only partially explain its variability. The purpose of this study was to estimate heritability of left ventricular mass. The study sample included adults in the original Framingham Heart Study and the Framingham Offspring Study who were not receiving antihypertensive medications and who were free of coronary heart disease, congestive heart failure, diabetes mellitus, renal insufficiency, valvular heart disease, and severe left ventricular hypertrophy. Intraclass correlations for left ventricular mass among first-degree relatives, second-degree relatives, and unrelated spouse pairs were calculated to determine the contribution of heredity to the variability in left ventricular mass. After adjustments for age, height, weight, and systolic blood pressure, the intraclass correlations between first-degree relatives were .15 (parent-child, P<.001) to .16 (siblings, P<.001), between second-degree relatives the correlation was .06 (P=NS), and between spouses it was .05 (P=NS). The estimated heritability of adjusted left ventricular mass was between .24 and .32. The proportion of the variance in sex-specific left ventricular mass explained by age, height, weight, and systolic blood pressure was .26 in men and .34 in women. On the basis of intraclass correlations for left ventricular mass, incorporation of adjusted left ventricular mass of a parent or sibling would increase the explained variance by an additional .02 to .03. Heredity explains a small, but discernible proportion of the variance in left ventricular mass. Studies are currently under way to identify genetic markers that predict an individual's predisposition to left ventricular hypertrophy. This knowledge may lead to advances in the prevention of left ventricular hypertrophy, which is strongly associated with cardiovascular morbidity and mortality.

Entities:  

Mesh:

Year:  1997        PMID: 9369250     DOI: 10.1161/01.hyp.30.5.1025

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  58 in total

1.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

2.  Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study.

Authors:  Suh-Hang Hank Juo; Marco R Di Tullio; Hsiu-Fen Lin; Tanja Rundek; Bernadette Boden-Albala; Shunichi Homma; Ralph L Sacco
Journal:  J Am Coll Cardiol       Date:  2005-08-16       Impact factor: 24.094

Review 3.  Drugs for the perioperative control of hypertension: current issues and future directions.

Authors:  Robert Feneck
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 4.  Genetics of the Framingham Heart Study population.

Authors:  Diddahally R Govindaraju; L Adrienne Cupples; William B Kannel; Christopher J O'Donnell; Larry D Atwood; Ralph B D'Agostino; Caroline S Fox; Marty Larson; Daniel Levy; Joanne Murabito; Ramachandran S Vasan; Greta Lee Splansky; Philip A Wolf; Emelia J Benjamin
Journal:  Adv Genet       Date:  2008       Impact factor: 1.944

5.  The 894T allele of endothelial nitric oxide synthase gene is related to left ventricular mass in African Americans with high-normal blood pressure.

Authors:  Rigobert Lapu-Bula; Alexander Quarshie; Deborah Lyn; Adefisayo Oduwole; Cheryl Pack; Jan Morgan; Sunday Nkemdiche; Priscilla Igho-Pemu; Anekwe Onwuanyi; Rongling Li; Elizabeth Ofili
Journal:  J Natl Med Assoc       Date:  2005-02       Impact factor: 1.798

6.  Change of genetic determinants of left ventricular structure in adolescence: longitudinal evidence from the Georgia cardiovascular twin study.

Authors:  Gaston K Kapuku; Dongliang Ge; Sarita Vemulapalli; Gregory A Harshfield; Frank A Treiber; Harold Snieder
Journal:  Am J Hypertens       Date:  2008-04-24       Impact factor: 2.689

7.  Electrocardiographic indices of left ventricular hypertrophy and repolarization phase share the same genetic influences: a twin study.

Authors:  Sara Mutikainen; Alfredo Ortega-Alonso; Markku Alén; Jaakko Kaprio; Jouko Karjalainen; Taina Rantanen; Urho M Kujala
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-10       Impact factor: 1.468

8.  Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation.

Authors:  Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

Review 9.  Genetics of common forms of heart failure: challenges and potential solutions.

Authors:  Christoph D Rau; Aldons J Lusis; Yibin Wang
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

10.  Formin homology 2 domain containing 3 variants associated with hypertrophic cardiomyopathy.

Authors:  Eric C Wooten; Virginia B Hebl; Matthew J Wolf; Sarah R Greytak; Nicole M Orr; Isabelle Draper; Jenna E Calvino; Navin K Kapur; Martin S Maron; Iftikhar J Kullo; Steve R Ommen; J Martijn Bos; Michael J Ackerman; Gordon S Huggins
Journal:  Circ Cardiovasc Genet       Date:  2012-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.